Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$48.1M Buy
1,058,091
+307,893
+41% +$15M 0.04% 526
2014
Q2
$38.7M Buy
750,198
+17,250
+2% +$848K 0.03% 558
2014
Q1
$35.8M Sell
732,948
-121,794
-14% -$5.91M 0.03% 524
2013
Q4
$37.1M Sell
854,742
-46,569
-5% -$1.91M 0.03% 501
2013
Q3
$34.4M Buy
901,311
+2,989
+0.3% +$105K 0.04% 470
2013
Q2
$27.9M Buy
+898,322
New +$26.8M 0.03% 504

Other funds holding VTRS

UBS's VTRS Position: Q3 2014 in Review

UBS increased its Viatris (VTRS) stake by 41% in Q3 2014, buying an estimated $15M and bringing the position to 1,058,091 shares worth $48.1M. The position accounts for 0.04% of the portfolio, ranked #526.

UBS first reported a position in VTRS in Q2 2013 and has held it in 6 quarters since. 629 funds tracked by Wall St. Rank hold VTRS as of Q3 2014.

  • UBS held 1,058,091 shares of Viatris worth $48.1M as of Q3 2014.
  • UBS bought 307,893 Viatris shares in Q3 2014, an estimated $15M.
  • Viatris made up 0.04% of UBS's portfolio in Q3 2014, its #526 holding.
  • UBS first reported a position in Viatris in Q2 2013 and has held it in 6 quarters since.
  • 629 funds tracked by Wall St. Rank held Viatris as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.